Journal
GASTROENTEROLOGIA Y HEPATOLOGIA
Volume 45, Issue 9, Pages 724-734Publisher
ELSEVIER ESPANA SLU
DOI: 10.1016/j.gastrohep.2022.02.005
Keywords
MAFLD; MASH; Steatohepatitis; Fibrosis; Hepatocellular carcinoma
Categories
Ask authors/readers for more resources
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, organized by the Spanish Association for the Study of the Liver (AEEH), provided updates on recent advances in basic and translational hepatology, focusing on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis, and end-stage hepatocellular carcinoma (HCC).
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC). (C) 2022 The Authors. Published by Elsevier Espana, S.L.U.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available